Communications and Public Outreach
The communications committee promotes the nonclinical statistics brand, its place within the pharmaceutical R&D development process, and its connections to the larger statistics community through publications, conference presentations and panel discussions, and student outreach. The committee is chaired by Dr. Kristi Griffiths (Eli Lilly).
Conferences
Conferences provide a valuable forum to network and grow. The calendar below displays conferences which have relevant content for the nonclinical statistics community in the month in which they typically occur. Check out the conference websites for details including dates and locations. Deadlines for submitting abstracts typically fall at least 6 months prior to a conference. A few key deadlines of note:
- Submission deadlines for the Joint Statistical Meetings typically begin in July of the year preceding the conference. JSM 2026 will be held in Boston, August 1 - 6 with the following submission deadlines:
- Invited Session Proposal Submission: July 16–September 3, 2025
- Short Course Proposal Submission: July 16 – September 30, 2025
- Computer Technology Workshop Proposal Submission: July 16, 2025 – January 15, 2026
- Topic-Contributed Session Proposal Submission: November 13 – December 10, 2025
- Contributed Session Abstract Submission: December 2, 2025 – February 2, 2026
- Submission deadlines for the Regulatory-Industry Statistics Workshop typically begin in November directly following that year's conference. RISW 2026 deadlines are not yet available but are expected to begin in November 2025.
Past Presentations and Publications
- Preparing for a Position in Nonclinical Biostatistics in the Pharmaceutical Industry: What You Need to Know!
(Video) Nonclinical statisticians from Bristol Myers Squibb, Janssen, and AstraZeneca share their experiences and perspectives working in the pharmaceutical industry.
- A Brief and Biased history of the Nonclinical Biostatistics Leaders’ Forum and the Evolution of the Nonclinical Biostatistics Conference Stan Altan (Janssen) and Don Bennett (Pfizer) in the Biopharmaceutical Report (Fall, 2021)
- Bayesian Methods in CMC-Has the Time Come For a Regulatory Guidance? co-authored by Paul Faya (Eli Lilly) Donald Berry (Berry Consultants) in the Biopharmaceutical Report (Summer, 2021)
- Why is Nonclinical Statistics Not Called By What it is? co-authored by Stan Altan (Janssen) and John Kolassa (Rutgers University) in the Biopharmaceutical Report (Spring, 2021)
- Report on the Nonclinical Biostatistics Scientific Working Group on P-Values co-authored by Stan Altan (Janssen), John Kolassa (Rutgers University), Steve Novick (AstraZeneca) in the Biopharmaceutical Report (Winter, 2021)
- A Brief History of Nonclinical Statistics in the Pharmaceutical Industry Stan Altan, Scott Clark, John Kolassa (JSM 2025)